Cargando…

Characterization of Two Variants at Met 1 of the Human LDLR Gene Encoding the Same Amino Acid but Causing Different Functional Phenotypes

Familial hypercholesterolemia (FH) is the most common genetic disorder of lipid metabolism, characterized by increased levels of total and LDL plasma cholesterol, which leads to premature atherosclerosis and coronary heart disease. FH phenotype has considerable genetic heterogeneity and phenotypic v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graça, Rafael, Fernandes, Rafael, Alves, Ana Catarina, Menezes, Juliane, Romão, Luísa, Bourbon, Mafalda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467959/ https://www.ncbi.nlm.nih.gov/pubmed/34572405 http://dx.doi.org/10.3390/biomedicines9091219

Ejemplares similares

High-Throughput Microscopy Characterization of Rare LDLR Variants
por: Graça, Rafael, et al.
Publicado: (2023)

Advantages and Versatility of Fluorescence-Based Methodology to Characterize the Functionality of LDLR and Class Mutation Assignment
por: Etxebarria, Aitor, et al.
Publicado: (2014)

Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity
por: Banerjee, Poulabi, et al.
Publicado: (2019)

MLb-LDLr: A Machine Learning Model for Predicting the Pathogenicity of LDLr Missense Variants
por: Larrea-Sebal, Asier, et al.
Publicado: (2021)

Circular RNA encoded MET variant promotes glioblastoma tumorigenesis
por: Zhong, Jian, et al.
Publicado: (2023)

The Hypocholesterolemic Potential of the Edible Algae Fucus vesiculosus: Proteomic and Quantitative PCR Analysis
por: André, Rebeca, et al.
Publicado: (2023)

Molecular modeling of LDLR aids interpretation of genomic variants
por: Klee, Eric W., et al.
Publicado: (2019)

Large-Scale CRISPR Screen of LDLR Pathogenic Variants
por: Li, Mengjing, et al.
Publicado: (2023)

Performance comparison of different classification algorithms applied to the diagnosis of familial hypercholesterolemia in paediatric subjects
por: Albuquerque, João, et al.
Publicado: (2022)

Comparative study on the performance of different classification algorithms, combined with pre- and post-processing techniques to handle imbalanced data, in the diagnosis of adult patients with familial hypercholesterolemia
por: Albuquerque, João, et al.
Publicado: (2022)

Validation of LDLr Activity as a Tool to Improve Genetic Diagnosis of Familial Hypercholesterolemia: A Retrospective on Functional Characterization of LDLr Variants
por: Benito-Vicente, Asier, et al.
Publicado: (2018)

PROS1 novel splice‐site variant decreases protein S expression in patients from two families with thrombotic disease
por: Menezes, Juliane, et al.
Publicado: (2017)

Vitamin D(3) supplementation of a high fat high sugar diet ameliorates prediabetic phenotype in female LDLR(−/−) and LDLR(+/+) mice
por: Kheder, Ramiar, et al.
Publicado: (2017)

Amino acid starvation‐induced LDLR trafficking accelerates lipoprotein endocytosis and LDL clearance
por: Chen, Ye, et al.
Publicado: (2022)

Endoplasmic reticulum quality control of LDLR variants associated with familial hypercholesterolemia
por: Kizhakkedath, Praseetha, et al.
Publicado: (2019)

Deep generative models of LDLR protein structure to predict variant pathogenicity
por: James, Jose K., et al.
Publicado: (2023)

Systematic Cell-Based Phenotyping of Missense Alleles Empowers Rare Variant Association Studies: A Case for LDLR and Myocardial Infarction
por: Thormaehlen, Aenne S., et al.
Publicado: (2015)

Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA
por: Bjune, Katrine, et al.
Publicado: (2018)

The LDLR, APOB, and PCSK9 Variants of Index Patients with Familial Hypercholesterolemia in Russia
por: Meshkov, Alexey, et al.
Publicado: (2021)

Portador Heterozigoto Composto de Hipercolesterolemia Familiar Causada por Variantes no LDLR
por: Pamplona-Cunha, Heloisa, et al.
Publicado: (2020)

Increased Inflammation in Atherosclerotic Lesions of Diabetic Akita-LDLr (−/−) Mice Compared to Nondiabetic LDLr (−/−) Mice
por: Engelbertsen, Daniel, et al.
Publicado: (2012)

Correction: Systematic Cell-Based Phenotyping of Missense Alleles Empowers Rare Variant Association Studies: A Case for LDLR and Myocardial Infarction
Publicado: (2015)

Saudi Familial Hypercholesterolemia Patients With Rare LDLR Stop Gain Variant Showed Variable Clinical Phenotype and Resistance to Multiple Drug Regimen
por: Awan, Zuhier Ahmed, et al.
Publicado: (2021)

The Preventive Effect of Exercise and Oral Branched-Chain Amino Acid Supplementation on Obesity-Induced Brain Changes in Ldlr−/−.Leiden Mice
por: Lohkamp, Klara J., et al.
Publicado: (2023)

Brown Algae Potential as a Functional Food against Hypercholesterolemia: Review
por: André, Rebeca, et al.
Publicado: (2021)

Metabolic Dysfunction and Asthma: Current Perspectives
por: Pite, Helena, et al.
Publicado: (2020)

Oxidative Stress and Lipid Accumulation Augments Cell Death in LDLR-Deficient RPE Cells and Ldlr (−/−) Mice
por: Sreekumar, Parameswaran Gangadharan, et al.
Publicado: (2022)

Functional analysis of four LDLR 5′UTR and promoter variants in patients with familial hypercholesterolaemia
por: Khamis, Amna, et al.
Publicado: (2015)

A novel indel variant in LDLR responsible for familial hypercholesterolemia in a Chinese family
por: Shu, Hongyan, et al.
Publicado: (2017)

The LDLR c.501C>A is a disease-causing variant in familial hypercholesterolemia
por: Hu, Haochang, et al.
Publicado: (2021)

Novel Presentation of Homozygous Familial Hypercholesterolemia With Homozygous Variants in Both LDLR and APOB Genes
por: Derenbecker, Robert, et al.
Publicado: (2019)

In vitro assessment of the pathogenicity of the LDLR c.2160delC variant in familial hypercholesterolemia
por: Lin, Shaoyi, et al.
Publicado: (2023)

Novel Tools for Comprehensive Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants
por: Jasiecki, Jacek, et al.
Publicado: (2023)

Primate-specific evolution of an LDLR enhancer
por: Wang, Qian-fei, et al.
Publicado: (2006)

T Cells in Atherosclerosis in Ldlr−/− and Apoe−/− Mice
por: Getz, Godfrey S., et al.
Publicado: (2018)

Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
por: Ma, Shizhan, et al.
Publicado: (2019)

Rare primary dyslipidaemias associated with low LDL and HDL cholesterol values in Portugal
por: Alves, Ana Catarina, et al.
Publicado: (2023)

A genetic variant in the LDLR promoter is responsible for part of the LDL-cholesterol variability in primary hypercholesterolemia
por: De Castro-Orós, Isabel, et al.
Publicado: (2014)

Identification of novel variants in the LDLR gene in Russian patients with familial hypercholesterolemia using targeted sequencing
por: Miroshnikova, Valentina V., et al.
Publicado: (2021)

Novel LDLR Variant in Familial Hypercholesterolemia: NGS-Based Identification, In Silico Characterization, and Pharmacogenetic Insights
por: Athar, Mohammad, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nnapdjfvttp5laatfrel9t046r